<DOC>
	<DOCNO>NCT02805049</DOCNO>
	<brief_summary>The main objective study describe pharmacokinetics prescribe echinocandins septic shock secondary peritonitis intra-abdominal fungal infection suspect proven .</brief_summary>
	<brief_title>Pharmacokinetic Study Echinocandins Patients With Septic Shock Following Secondary Peritonitis</brief_title>
	<detailed_description>The secondary objective study : - Determine whether current recommended dos caspofungin achieve Pharmacokinetic/Pharmacodynamic ( PK/PD ) target molecule . - Determine whether current recommended dos micafungin achieve PK / PD target molecule - Describe peritoneal concentration echinocandins secondary peritonitis complicate septic shock - Identify via model PK / PD parameter base monte Carlo simulation optimal dose regimen caspofungin micafungin population</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Micafungin</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>The emergency inclusion procedure correctly apply accord French law ( signature consent form patientdesignated trusted person family member , medical decision proceed patient inclusion latter two person unavailable ) OR signature consent form patient The patient must insure beneficiary health insurance plan The patient 18 year age older The patient beed admit ICU septic shock accompany secondary peritonitis Patient require antifungal treatment via echinocandins ( caspofungin micafungin ) A venous arterial access blood sample already place routine care The patient participate interventional study may affect result present study , participate study within past 3 month The patient judicial protection , adult guardianship The patient pregnant , parturient breastfeed Moribund patient Known positive serology human immunodeficiency virus ( HIV ) Known positive serology hepatitis C Known diagnosis tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>